Ioanna E. Galani

2.7k total citations · 1 hit paper
25 papers, 1.8k citations indexed

About

Ioanna E. Galani is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Ioanna E. Galani has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 7 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Ioanna E. Galani's work include Immune Cell Function and Interaction (8 papers), Immune Response and Inflammation (6 papers) and interferon and immune responses (5 papers). Ioanna E. Galani is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Immune Response and Inflammation (6 papers) and interferon and immune responses (5 papers). Ioanna E. Galani collaborates with scholars based in Greece, United States and Germany. Ioanna E. Galani's co-authors include Evangelos Andreakos, Adelheid Cerwenka, Ourania Koltsida, Elisabeth Suri‐Payer, Marco Wendel, Vasiliki Triantafyllia, Maria Manioudaki, Athanasios Stavropoulos, Kalliopi Thanopoulou and Norman Nausch and has published in prestigious journals such as Blood, Immunity and Nature Immunology.

In The Last Decade

Ioanna E. Galani

24 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness

2017 349 citations Ioanna E. Galani, Vasiliki Triantafyllia et al. Immunity profile →

Peers

Ioanna E. Galani

IMMUN

ONCOL

EPIDE

Shuo Li China

Christophe Paget France

Sophia Davidson Australia

Leslie Chávez‐Galán Mexico

Michael L. Freeman United States

Christina E. Zielinski Germany

Nathalie Dhédin France

M. Tarek Elghetany United States

Marisa Benagiano Italy

Achille Broggi Italy

Shuo Li China

Ioanna E. Galani

669 ×0.6

IMMUN

377 ×0.8

169 ×0.4

ONCOL

194 ×0.5

EPIDE

436 ×1.3

Citations per year, relative to Ioanna E. Galani Ioanna E. Galani (= 1×) peers Shuo Li

Countries citing papers authored by Ioanna E. Galani

Since Specialization

Citations

This map shows the geographic impact of Ioanna E. Galani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioanna E. Galani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioanna E. Galani more than expected).

Fields of papers citing papers by Ioanna E. Galani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ioanna E. Galani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioanna E. Galani. The network helps show where Ioanna E. Galani may publish in the future.

Co-authorship network of co-authors of Ioanna E. Galani

This figure shows the co-authorship network connecting the top 25 collaborators of Ioanna E. Galani. A scholar is included among the top collaborators of Ioanna E. Galani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioanna E. Galani. Ioanna E. Galani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tzouvelekis, Argyrios, et al.. (2025). Transcriptomic analysis reveals shared deregulated neutrophil responses in COVID-19 and idiopathic pulmonary fibrosis. Respiratory Research. 26(1). 213–213.

Siouti, Eleni, Maria Salagianni, Maria Manioudaki, et al.. (2024). Notch signaling in adipose tissue macrophages prevents diet‐induced inflammation and metabolic dysregulation. European Journal of Immunology. 54(5). e2350669–e2350669. 9 indexed citations

Kotsovilis, Sotirios, Maria Salagianni, Aimilia Varela, et al.. (2024). Comprehensive Analysis of 1-Year-Old Female Apolipoprotein E-Deficient Mice Reveals Advanced Atherosclerosis with Vulnerable Plaque Characteristics. International Journal of Molecular Sciences. 25(2). 1355–1355. 2 indexed citations

Foster, Martyn, et al.. (2024). Neutrophil-derived Activin-A moderates their pro-NETotic activity and attenuates collateral tissue damage caused by Influenza A virus infection. Frontiers in Immunology. 15. 1302489–1302489. 3 indexed citations

Galani, Ioanna E., et al.. (2024). Type III interferons in innate and adaptive immunity in the respiratory tract. Current Opinion in Immunology. 87. 102430–102430. 3 indexed citations

Galani, Ioanna E., Abhishek S. Rao, Vasiliki Triantafyllia, et al.. (2022). Severity of neonatal influenza infection is driven by type I interferon and oxidative stress. Mucosal Immunology. 15(6). 1309–1320. 9 indexed citations

Galani, Ioanna E., et al.. (2022). Protocol for influenza A virus infection of mice and viral load determination. STAR Protocols. 3(1). 101151–101151. 14 indexed citations

Galani, Ioanna E. & Evangelos Andreakos. (2021). Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities. Seminars in Immunology. 55. 101522–101522. 13 indexed citations

Galani, Ioanna E., Eynav Klechevsky, & Evangelos Andreakos. (2019). Human and translational immunology in the third millennium: progress, challenges and opportunities. Nature Immunology. 20(12). 1568–1573. 2 indexed citations

10.

Andreakos, Evangelos, Ivan Zanoni, & Ioanna E. Galani. (2018). Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control. Current Opinion in Immunology. 56. 67–75. 72 indexed citations

11.

Chrysanthopoulou, Akrivi, Konstantinos Kambas, Dimitrios Stakos, et al.. (2017). Interferon lambda1/IL‐29 and inorganic polyphosphate are novel regulators of neutrophil‐driven thromboinflammation. The Journal of Pathology. 243(1). 111–122. 74 indexed citations

12.

Andreakos, Evangelos, Maria Salagianni, Ioanna E. Galani, & Ourania Koltsida. (2017). Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract. Frontiers in Immunology. 8. 1232–1232. 60 indexed citations

13.

Galani, Ioanna E., Vasiliki Triantafyllia, Ourania Koltsida, et al.. (2017). Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness. Immunity. 46(5). 875–890.e6. 349 indexed citations breakdown →

14.

Galani, Ioanna E., Ourania Koltsida, & Evangelos Andreakos. (2015). Type III interferons (IFNs): Emerging Master Regulators of Immunity. Advances in experimental medicine and biology. 850. 1–15. 29 indexed citations

15.

Semitekolou, Maria, Ioanna E. Galani, Ioannis Morianos, et al.. (2013). CXCL13 Production in B Cells via Toll-like Receptor/Lymphotoxin Receptor Signaling is Involved in Lymphoid Neogenesis in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 187(11). 1194–1202. 78 indexed citations

16.

Skevaki, Chrysanthi, et al.. (2011). Treatment of Viral Conjunctivitis with Antiviral Drugs. Drugs. 71(3). 331–347. 40 indexed citations

17.

Ni, Jing, Ioanna E. Galani, Adelheid Cerwenka, Volker Schirrmacher, & Philippe Fournier. (2010). Antitumor vaccination by Newcastle Disease Virus Hemagglutinin–Neuraminidase plasmid DNA application: Changes in tumor microenvironment and activation of innate anti-tumor immunity. Vaccine. 29(6). 1185–1193. 24 indexed citations

18.

Kießling, Michael K., et al.. (2009). Inhibition of Constitutively Activated Nuclear Factor-κB Induces Reactive Oxygen Species- and Iron-Dependent Cell Death in Cutaneous T-Cell Lymphoma. Cancer Research. 69(6). 2365–2374. 105 indexed citations

19.

Nausch, Norman, Ioanna E. Galani, Eva Schlecker, & Adelheid Cerwenka. (2008). Mononuclear myeloid-derived “suppressor” cells express RAE-1 and activate natural killer cells. Blood. 112(10). 4080–4089. 128 indexed citations

20.

Wendel, Marco, Ioanna E. Galani, Elisabeth Suri‐Payer, & Adelheid Cerwenka. (2008). Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands. Cancer Research. 68(20). 8437–8445. 291 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact